Congress temporarily suspends tariffs on imported formula to reduce cost
The Senate today passed and sent to the president for his signature the Formula Act (H.R. 8351), bipartisan legislation that would suspend tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage to help health care providers and families locate formula.
Related News Articles
Headline
The Health Resources and Services Administration has awarded approximately $7 million in grants to seven recipients in the fiscal year 2026 cohort of its Rural…
Headline
In a new blog by Aisha Syeda, senior program manager at AHA, learn how you can participate in the first Better Health for Mothers and Babies Awareness Week,…
Blog
Every mother and baby deserves the opportunity for a healthy start. Hospitals and health systems help make that possible by providing care throughout pregnancy…
Headline
In part two of this special three-part Advancing Health podcast series, hear how leaders are creating new pathways into the workforce, investing in training,…
Headline
In episode one of Frontiers, a special three-part podcast series from the AHA that examines maternal health in rural America, learn how rural hospital leaders…
Headline
Join the AHA’s Better Health for Mothers and Babies Initiative in observing NICU Awareness Month in September and NICU Awareness Day on Sept. 30. From Sept. 28…